Cataract Avoidance With Proton Therapy in Ocular Melanomas | Zendy

Juliette Thariat | Zendy; Sophie Jacob | Zendy; JeanPierre Caujolle | Zendy; C. Maschi | Zendy; Stéphanie Baillif | Zendy; G. Angellier | Zendy; Thibaud Mathis | Zendy; Laurence Rosier | Zendy; A. Carnicer | Zendy; J. Hérault | Zendy; J. Salleron | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Cataract Avoidance With Proton Therapy in Ocular Melanomas

Author(s) -

Juliette Thariat,

Sophie Jacob,

JeanPierre Caujolle,

C. Maschi,

Stéphanie Baillif,

G. Angellier,

Thibaud Mathis,

Laurence Rosier,

A. Carnicer,

J. Hérault,

J. Salleron

Publication year - 2017

Publication title -

investigative ophthalmology and visual science

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.935

H-Index - 218

eISSN - 1552-5783

pISSN - 0146-0404

DOI - 10.1167/iovs.17-22557

Subject(s) - cataracts , medicine , lens (geology) , ophthalmology , radiation therapy , surgery , petroleum engineering , engineering

The lens is a radiosensitive organ. Any dose of cephalic irradiation can give rise to radiation-induced cataracts. Contrary to other forms of radiotherapy, proton therapy (PT) can spare all or part of the lens due to accurate dose deposition. We investigated whether a lens-sparing approach was relevant to avoid cataracts in uveal melanoma patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research